Pharma
Women's Networking Event - Financing your future
As part of marking International Women’s Day, join our networking event to hear how the EMBA programmes can help you achieve your goals and provide a real return on your investment. We will share with you the results of our research about the financial challenges women face to undertak...
User-centred design; the key to successfully developing medical devices
eg technology launch free eBook to help organisations understand the importance of User-centred design in their medical device design and development programme. ...
Survey to gather insights on the long term innovation vision for Cambridge
Innovate Cambridge writes...As part of the Innovate Cambridge process, we would like to gather your insights and to do this we are launching two short surveys. These will provide an opportunity to highlight the issues that matter most to you and your organisation. ...
Assisted dying and a new treatment for Peyronie’s disease form part of a series of health events at Cambridge Festival 2023
Should assisted dying be legalised? Could erectile dysfunction caused by fibrosis (Peyronie’s disease) be cured by a new drug combination? What can dogs teach us about obesity? Why do young people eat what they do? These questions are part of a wide-ranging series of events at this y...
How does rare disease prevalence impact drug pricing in England?
This article was originally published in PharmaPhorum. In this second article of a three-part series exploring pricing in Europe, CRA’s Life Sciences Practice team discusses the role that disease rarity plays in reimbursement decisions among payers in England, comparing assessments by ...
World Orphan Drug Congress Europe 2022
CRA is a proud sponsor of the congress. Cecile Matthews and Bhavesh Patel present their session titled “Project LEOPARD (Long-term Evolution & Outlook for Patient Access in Rare Disease): Initial findings on what the future holds.” Michele Pistollato presents his session titled “P...
Part 2: Low-priced oncology disruptors - The cuckoo in the PD-1/PD-L1 nest or the runt of the clutch?
Part II of this article was originally published in PharmaPhorum.
Part 1: Low-priced oncology disruptors - The cuckoo in the PD-1/PD-L1 nest or the runt of the clutch?
Part I of this article was originally published in PharmaPhorum.
Seed investment to further advance our pioneering antiaging research
Five Alarm Bio writes...we are delighted to announce the close of our seed investment to further advance our pioneering antiaging research. The funding will enable our team to test new compounds for their ability to extend the healthy lifespan of cells and improve their function in dis...
ICRISAT and Eagle Genomics partnership to accelerate microbiome-based solutions to drive global climate resilience, sustainable food systems and improved nutrition
ICRISAT and Eagle Genomics sign Memorandum of Understanding